BNF 82 (British National Formulary) September 2021: 82: September 2021 - March 2022

Product Information

Blood Results in Clinical Practice: A Practical Guide to Interpreting Blood Test Results - 2nd ed. (2019) National Institute for Health and Care Excellence (2020) Acute coronary syndromes. NG185. Available at:https://www.nice.org.uk/guidance/ng185(Accessed: 7 December 2020).

Biological drugs are drugs produced or obtained from a biological source by biotechnological processes, such as recombinant DNA technology. The size and complexity of biological drugs, as well as the method of their production, can result in a certain degree of natural renewal of the molecules of the same active substance, especially for different groups of drugs. This distinction is kept within strictly acceptable limits. Examples of biological drugs include insulin and monoclonal antibodies. g Biological medicines must be prescribed and the prescribed label must be provided to prevent unintentional transmission. Automatic label exchange at the point of delivery is not suitable for biological medicines. h Biosimal drugs Pharmaceutical Excipients: Properties, Functionality and Applications in Research and Industry (2017) Pholcodine-containing cough and cold medicines: withdrawal from UK market as a precautionary measure Mylan. Acamprosate 333 mg Gastro-resistant Tablets SmPC. 2020 [cited 2020 Dec 4]Available from: https://www.medicines.org.uk/emc/product/2729/smpc

Pre-treatment screening advice on genetic testing for aminoglycoside exposure posing risk to hearing The BNF is authored by the Joint Formulary Committee and you can access it via our Medicines Complete subscription. Drug information is taken from the manufacturers' product literature, medical and pharmaceutical literature, UK health departments, regulators and professional bodies. The advice is taken from the clinical literature and reflects, where possible, evaluations of evidence from a variety of sources. BNF also considers national guidelines and increased safety care to be authoritative. In addition, the newsroom received advice in all areas of treatment from specialist clinics; this ensures that BNF's recommendations are relevant to practice. Physicochemical Principles of Pharmacy in Manufacture, Formulation and Clinical Use - 6th ed. (2016)

BNF is a joint publication of the British Medical Association and the Royal Pharmaceutical Society. It is issued under the auspices of a Joint Formulation Committee composed of representatives of two professional bodies, the British Health Departments, the Agency for the Regulation of Medicines and Medical Products and the manufacturer of national guidelines. Dental Advisory Group oversees the preparation of dental and oral treatment management advice; the group includes representatives of the British Dental Association and representatives of the British Health Departments. The Prescribing Physicians Advisory Group provides advice on nurse-related content and includes representatives from different parts of the nursing community and the UK's health departments. An integral part of the UK’s healthcare infrastructure and relied on by health professionals who prescribe, dispense, and administer medicines globally. Containing guidance on best practice in prescribing, as well as legal and ethical considerations, BNF supports safe and effective decision-making at the point of care.

Get the BNF + BNFC app

Management of iron deficiency anaemia, including update to oral iron dosing and monitoring based on British Society of Gastroenterology guidelines Joint Formulary Committee (2021) British National Formulary, 81, March-September 2021. London: BMJ Group and Pharmaceutical Press.